Photodynamic therapy in cholangiocarcinomas.

Details

Serval ID
serval:BIB_A6AFB4B341F7
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Photodynamic therapy in cholangiocarcinomas.
Journal
Best practice & research. Clinical gastroenterology
Author(s)
Ortner M.A.
ISSN
1521-6918
Publication state
Published
Issued date
02/2004
Peer-reviewed
Oui
Volume
18
Number
1
Pages
147-54
Language
english
Notes
Publication types: Journal Article ; Review - Old month value: Febppublish
Abstract
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time of diagnosis are candidates for curative surgery. In patients with advanced non-resectable cholangiocarcinoma palliative treatment options are limited. Until now, insertion of endoprostheses for the treatment of cholestasis has been the method of choice. However, tumour growth cannot be influenced and so that prognosis is dismal. Although radiotherapy and chemotherapy are frequently used, prospective, randomized trials showing an improvement in survival time are missing. Encouraging results from prospective, single-arm phase II trials and a randomized trial using photodynamic therapy (PDT) in non-resectable cholangiocarcinoma indicate considerable benefit on survival with a good quality of life. Furthermore, PDT is well tolerated, with only few specific side-effects. This is of great importance in patients with short life expectancy. PDT should therefore be offered to all patients with non-resectable cholangiocarcinoma. However, before initiating PDT or any other palliative measure, a proper staging and a surgical consultation is necessary to avoid missing a curative surgical option.
Keywords
Bile Duct Neoplasms/drug therapy, Bile Duct Neoplasms/mortality, Bile Ducts, Intrahepatic, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/mortality, Clinical Trials, Phase II as Topic, Dihematoporphyrin Ether/therapeutic use, Female, Follow-Up Studies, Humans, Male, Neoplasm Staging, Palliative Care/methods, Photochemotherapy/adverse effects, Photochemotherapy/methods, Prospective Studies, Randomized Controlled Trials as Topic, Risk Assessment, Survival Analysis, Treatment Outcome
Pubmed
Web of science
Create date
25/01/2008 17:08
Last modification date
20/08/2019 16:11
Usage data